Understanding how the body defends against vaginal yeast infections
Mucosal host defense against vaginal candidiasis
This study is looking at how your immune system fights off vaginal yeast infections, specifically focusing on certain immune cells and signals that help protect you, with the hope of finding better ways to prevent and treat these common infections for women.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11123494 on NIH RePORTER |
What this research studies
This research investigates the immune response to vaginal candidiasis, a common fungal infection caused by Candida albicans. It focuses on the role of specific immune cells and cytokines in protecting the vaginal mucosa from infection. By examining how these immune components interact, the study aims to uncover new insights into the body's defense mechanisms against this prevalent condition. The findings could lead to improved prevention and treatment strategies for women suffering from recurrent infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who experience recurrent vaginal candidiasis or have a history of vulvovaginal candidiasis.
Not a fit: Patients who do not experience vaginal candidiasis or have other unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapies or vaccines to prevent recurrent vaginal candidiasis, significantly improving the quality of life for affected women.
How similar studies have performed: Previous research has shown success in understanding immune responses to fungal infections in other body sites, suggesting potential for breakthroughs in this area as well.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Gaffen, Sarah L — University of Pittsburgh at Pittsburgh
- Study coordinator: Gaffen, Sarah L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.